Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)

Summary

The expanded access program allows people to gain access to an unlicensed treatment on compassionate grounds. This expanded access program provides adults with refractory metastatic colorectal cancer (mCRC) and who cannot neither adequately be treated by current standard of care nor participate in a clinical study access to TAK-113 until TAK-113 becomes commercially available in the respective country or the adult does no longer seem to benefit from treatment with TAK-113.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications